All kidney transplant patients who receive everolimus as maintenance immunosuppressive therapy in transplant center of Chiang Mai University hospital. Chronic allograft complications, Everolimus, Intrapatient variability, Kidney transplantation
Conditions
Interventions
We included all kidney transplant patients who receive EVR as maintenance immunosuppressive therapy in our transplant center. It is estimated that minimum of 100 patients will be achieved.
Other
kidney transplant recipients
Sponsors
Chiang Mai University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Age >18 years old at the time of transplant - Both living-related and deceased-donor kidney transplant patients - Receive EVR as maintenance immunosuppressive therapy for at least 3 months and have EVR C0 levels for at least 3 values
Exclusion criteria
Exclusion criteria: Biopsy-proven acute or chronic allograft rejection prior to receive EVR
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relation ship between IPV of EVR and chronic allograft complications at 36 months after end of the intervention Univariable analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| Association between chronic allograft complications and transplant-related factors at 36 months after end of the intervention Multivariable analysis | — |
Countries
Thailand
Contacts
Public ContactPrit Kusirisin
Chiang Mai University
Outcome results
None listed